Actual - Legal

Today, February 13, 2007, the current federal estate tax exemption is set at $2 million dollars. It means

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

that people with less than $2 million dollars worth of assets can do their own planning. Contingent upon

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

the complexity of one’s estate, number of heirs, varied assets, certain planning calls for an expert. But,

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

for regular folks leaving money to their heirs, there are other ways to do your own estate planning, offse

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t probate expenses and maximize inheritance:

1. First, visit your state’s web site to determine how much

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

he estate tax exemption is set in your state.

2. Various web sites such as LawDepot.com feature dow

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

loadable wills, power of attorney agreements and other legal documents. [These power of attorney template

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

contracts run about $20.]

3. Review life insurance and retirement policies. Generally, these acc

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

unts can be transferred directly onto beneficiaries.

4. The same theory applies to taxable accoun

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

s such as: savings, mutual funds and other investment income account. As long as the benefactor entitles

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

he accounts as “transfer on death” “pay on death” to heirs, proceeds should be directly passed on. However

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

, more intricately individualized financial situations may require differ.

Estate Planning Ti

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

: Large to mega-sized estates necessitate the professional guidance of a lawyer or certified estate p

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

anner.

5. For items #2 and 3 (above), title assets to simplify the financial transfer of your deat

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

h.

6. Open a living trust to stockpile assets.

7. In cases where real estate is owned in

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

another state or country, an attorney with expertise in international law and real estate planning may be

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ecessary.

8. There’s no need to wait until death. Sharing the wealth now can save heirs taxation

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

in the long-term.

Federal-estate tax exemption fact: by the year 2009, the federal-estate

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tax exemption is slated to grow to $3.5 million.

For more elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

/" target=_blank> personal finance articles and consumer tips bookmark, TheConsumerJournal.com.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Actual - 8-Tactics on Easy Estate Planning

Related Articles: